Online citations, reference lists, and bibliographies.
← Back to Search

Human Brain Cortex: Mitochondrial Oxidative Damage And Adaptive Response In Parkinson Disease And In Dementia With Lewy Bodies.

A. Navarro, A. Boveris, M. J. Bández, María-Jesús Sánchez-Pino, C. Gómez, G. Muntané, I. Ferrer
Published 2009 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Frontal cortex samples from frozen human brains were used to assess tissue respiration; content of mitochondria; mitochondrial oxygen uptake; activity of respiratory complexes and of mitochondrial nitric oxide synthase (mtNOS); content of cytochromes a, b, and c; oxidative damage (protein carbonyls and TBARS); and expression of Mn-SOD in patients with Parkinson disease (PD) and with dementia with Lewy bodies (DLB) in comparison with those of normal healthy controls. Brain cortex and mitochondrial O(2) uptake and complex I activity were significantly lower in PD and DLB, whereas mtNOS activity, cytochrome content, expression of Mn-SOD, mitochondrial mass, and oxidative damage were significantly higher in the frontal cortex in PD and DLB. The decreases in tissue and mitochondrial O(2) uptake and in complex I activity are considered the consequences of mitochondrial oxidative damage. The increases in mtNOS activity and in mitochondrial mass are interpreted as an adaptive response of the frontal cortex that involves increased NO signaling for mitochondrial biogenesis. The adaptive response would partially compensate for mitochondrial dysfunction in these neurodegenerative diseases and would afford a human evolutionary response to shortage of ATP in the frontal cortex.
This paper references
The metabolism of rat brain mitochondria. Preparation and characterization.
J. B. Clark (1970)
10.1016/0005-2728(71)90002-8
Reduction of mitochondrial components by durohydroquinone.
A. Boveris (1971)
10.1085/JGP.62.6.756
Mechanisms for Intracellular Calcium Regulation in Heart I. Stopped-Flow Measurements of Ca++ Uptake by Cardiac Mitochondria
A. Scarpa (1973)
10.1073/PNAS.77.5.2777
Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species.
J. M. Tolmasoff (1980)
10.1016/S0140-6736(83)92711-3
Medicine and the Law
D. Brahams (1983)
10.1016/s0021-9258(18)45598-6
Age-related changes in oxidized proteins.
C. Oliver (1987)
10.1016/0891-5849(88)90023-8
Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes.
C. Fraga (1988)
10.1016/0006-291X(89)91141-8
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
Y. Mizuno (1989)
10.1016/S0140-6736(89)92366-0
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
A.H.V. Schapira (1989)
10.1111/j.1471-4159.1990.tb02325.x
Mitochondrial Complex I Deficiency in Parkinson's Disease
A. H. V. Schapira (1989)
10.1111/j.1471-4159.1990.tb05809.x
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
A. Schapira (1990)
10.1016/0891-5849(91)90009-R
Oxygen free radicals and Parkinson's disease.
J. Adams (1991)
10.1093/ajcn/53.1.373S
Antioxidants and aging.
R. Cutler (1991)
10.1016/0005-2728(92)90224-p
Human mitochondrial complex I dysfunction.
J. Cooper (1992)
10.1212/WNL.47.5.1113
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
I. McKeith (1996)
10.1097/00005072-199603000-00001
Neuropathology of Parkinson's Disease
L. Forno (1996)
10.1016/S0014-5793(97)01397-5
Nitric oxide synthase activity in mitochondria
P. Ghafourifar (1997)
10.1111/j.1750-3639.1998.tb00156.x
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
P. Ince (1998)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
M. Baba (1998)
10.1074/jbc.273.18.11038
Production of Nitric Oxide by Mitochondria*
C. Giulivi (1998)
10.1073/PNAS.95.11.6469
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
M. Spillantini (1998)
10.1111/j.1750-3639.1999.tb00552.x
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
M. Hashimoto (1999)
10.1016/S0076-6879(99)01082-4
Regulation of mitochondrial respiration by adenosine diphosphate, oxygen, and nitric oxide.
A. Boveris (1999)
Dementia with Lewy bodies
M. Jf (2000)
10.1212/WNL.54.5.1050
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
I.G. McKeith (2000)
10.1073/pnas.241380298
Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection
A. Kanai (2001)
10.1007/978-1-4615-1249-3_12
Dementia with Lewy bodies.
P. Ince (2001)
10.1016/S0891-5849(02)00804-3
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
B. Giasson (2002)
10.1152/AJPREGU.00537.2001
Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice.
A. Navarro (2002)
10.1016/S0076-6879(02)59196-5
Pharmacological regulation of mitochondrial nitric oxide synthase.
A. Boveris (2002)
10.1074/JBC.M204580200
The Modulation of Mitochondrial Nitric-oxide Synthase Activity in Rat Brain Development*
N. Riobo (2002)
10.1074/JBC.M205256200
Biochemistry of Mitochondrial Nitric-oxide Synthase*
S. Elfering (2002)
10.1007/s00415-003-1303-x
Aggregation of α-synuclein in the pathogenesis of Parkinson’s disease
T. Iwatsubo (2003)
10.1089/152308603322110841
Kidney mitochondrial nitric oxide synthase.
A. Boveris (2003)
10.1002/9781444341256
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
D. W. Dickson (2003)
10.1016/J.MAM.2004.02.007
Mitochondrial enzyme activities as biochemical markers of aging.
A. Navarro (2004)
10.1152/AJPREGU.00226.2004
Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging.
A. Navarro (2004)
10.1016/J.MAM.2004.02.014
Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease.
M. C. Carreras (2004)
10.1073/PNAS.0405432101
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals.
E. Nisoli (2004)
10.1152/AJPREGU.00208.2003
Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer.
A. Navarro (2004)
10.1152/AJPENDO.00223.2005
Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle.
A. Navarro (2005)
10.1016/j.nbd.2004.12.009
Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease
H. Poon (2005)
10.1152/AJPHEART.00812.2004
Heart mitochondrial nitric oxide synthase is upregulated in male rats exposed to high altitude (4,340 m).
G. Gonzales (2005)
10.1097/01.jnen.0000179050.54522.5a
Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
E. Dalfo (2005)
10.1111/j.1471-4159.2006.03990.x
The role of mitochondria in inherited neurodegenerative diseases
J. Kwong (2006)
10.1016/S1474-4422(06)70471-9
Epidemiology of Parkinson's disease
L. M. D. Lau (2006)
10.1523/JNEUROSCI.0984-06.2006
Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled
P. Keeney (2006)
10.1038/ng1769
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
A. Bender (2006)
10.1016/j.neulet.2007.01.026
Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease
I. Ferrer (2007)
10.1080/13546800701202316
“Machiavellianism” and frontal dysfunction: Evidence from Parkinson's disease
P. McNamara (2007)
10.1152/PHYSREV.00029.2006
Nitric oxide and peroxynitrite in health and disease.
P. Pacher (2007)
10.1152/AJPCELL.00213.2006
The mitochondrial energy transduction system and the aging process.
A. Navarro (2007)
10.1371/journal.pone.0001749
Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome
P. Finocchietto (2008)
10.1152/AJPREGU.00492.2007
Hippocampal mitochondrial dysfunction in rat aging.
A. Navarro (2008)
10.1016/j.addr.2008.05.002
Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants.
A. Navarro (2008)
10.1016/S1474-4422(07)70327-7
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
A. Schapira (2008)
10.1002/iub.46
Brain mitochondrial dysfunction in aging
A. Boveris (2008)
10.1016/j.neurobiolaging.2006.10.022
Early α-synuclein lipoxidation in neocortex in Lewy body diseases
E. Dalfo (2008)



This paper is referenced by
10.1016/j.brainres.2021.147434
Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal
Nitya Subrahmanian (2021)
10.3390/brainsci11030373
Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
S. Avazzadeh (2021)
10.1186/s13024-021-00439-2
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Manuela Gries (2021)
Title: Systematic review of gene expression studies in people with Lewy Body Dementia Short running title: Gene expression changes in Lewy Body Dementia Authors and affiliations:
Anisa Chowdhury (2020)
10.1017/neu.2020.13
Systematic review of gene expression studies in people with Lewy body dementia
Anisa Chowdhury (2020)
10.1155/2020/6281454
Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease
A. Miranda-Díaz (2020)
10.1186/s13024-020-00367-7
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge (2020)
10.3389/fphys.2020.00360
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI
C. Foster (2020)
Effect of Immobilization Acute Stress on Spatial Learning and Memory of Male Rats and Its Effect Moderation through Swimming
M. Ghorbani (2020)
10.1016/j.pnpbp.2019.109674
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin (2019)
10.3389/fphar.2018.01572
Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
V. Samokhvalov (2019)
10.1016/j.freeradbiomed.2019.03.001
Complex I syndrome in striatum and frontal cortex in a rat model of Parkinson disease
L. Valdez (2019)
10.1039/c8fo01843j
(+)-Catechin inhibits heart mitochondrial complex I and nitric oxide synthase: functional consequences on membrane potential and hydrogen peroxide production.
D. Iglesias (2019)
10.3233/JAD-170609
Sisyphus in Neverland
I. Ferrer (2018)
10.1007/s12640-018-9976-1
Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion
N. F. Marques (2018)
10.1007/s11910-018-0893-8
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison (2018)
10.1007/s00044-018-2254-1
Antioxidant properties of Calendula officinalis L. (Asteraceae) on Fe2+-initiated peroxidation of rat brain mitochondria
P. Zeinsteger (2018)
10.1016/j.neuint.2018.10.015
Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function
Norma Serrano-García (2018)
10.1016/j.bbrc.2018.08.078
Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells.
T. Omura (2018)
10.1111/bpa.12511
Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies
G. Santpere (2018)
10.17863/CAM.24553
The role of germline and somatic nuclear and mitochondrial DNA variation in neurodegenerative disorders
M. Keogh (2018)
10.1111/bpa.12474
Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia
P. Garcia‐Esparcia (2018)
10.1007/s00702-017-1821-9
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. Jellinger (2017)
Molecular mechanisms of autophagy and the effect of autophagy dysfunction on mitochondrial function
Elsje G. Otten (2017)
The role of TIGAR in Parkinson´s Disease
R. López (2017)
Age-related differences in stress response : Increase markers for oxidative stress and liver damage after heat stress in aged rats ?
M. Schenk (2017)
10.1021/acschemneuro.7b00152
The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage.
Sandro Huenchuguala (2017)
10.1155/2017/5398542
Salidroside Protects against MPP+-Induced Neuronal Injury through DJ-1-Nrf2 Antioxidant Pathway
Leitao Wu (2017)
10.1142/9789814578783_0004
Optic disc drusen
Nagham S Al-Zubidi (2017)
10.1016/j.freeradbiomed.2017.07.027
Hydrogen peroxide, nitric oxide and ATP are molecules involved in cardiac mitochondrial biogenesis in Diabetes.
Silvina S. Bombicino (2017)
10.18632/oncotarget.20801
Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
C. Guo (2017)
10.3389/fneur.2017.00089
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
P. Garcia‐Esparcia (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar